Johns Hopkins study links mild pancreatic duct dilatation to higher cancer risk
Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by…
‘I Cry Every Time I Talk About It’ (Exclusive)
NEED TO KNOW Jaclyn Hayes Lin was 32 weeks pregnant when she was diagnosed with stage 4 pancreatic…
Study advances the possibility of age-based pancreatic cancer treatment
While some risk factors for cancer can be mitigated through lifestyle choices such as diet or exercise, aging…
Tip Sheet: How patient advocacy shapes research and care, how HIV/AIDS research benefits other diseases — and invasive lobular breast cancer awareness
SEATTLE — Nov. 4, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
Northwestern team develops antibody to expose hidden pancreatic cancer cells
Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have…
Novel treatment disrupts tumor immunosuppression in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%. University…
New genetic test redefines diagnosis and management of hereditary pancreatitis
A new genetic test developed at Mayo Clinic is redefining how clinicians diagnose and manage hereditary pancreatitis. Pancreatitis, inflammation…